Fate’s management team has the passion and experience to explore new biology, develop innovative therapeutics, create formidable intellectual property, launch new business models and foster high-value strategic collaborations.

Scott Wolchko
Scott Wolchko
President & CEO
Stewart Abbot
Stewart Abbot, Ph.D.
Chief Development Officer
Dan Shoemaker
Dan Shoemaker, Ph.D.
Chief Scientific Officer
3bio goes here
Chris Storgard
Chris Storgard, M.D.
Chief Medical Officer
Cindy Tahl
Cindy Tahl, J.D.
General Counsel
Bob Valamehr
Bob Valamehr, Ph.D.
Vice President of Cancer Immunotherapy
6bio goes here
Jim Beitel
Jim Beitel
Senior Vice President, Corporate Development
8bio goes here9